Melatonin modulates microsomal PGE synthase 1 and NF-E2-related factor-2-regulated antioxidant enzyme expression in LPS-induced murine peritoneal macrophages

British Journal of Pharmacology

Volumn 171, Issue 1, 2014, Pages 134-144

  Aparicio Soto, M ^a   Alarcon De La Lastra C ^a   Cardeno A ^a   Sanchez Fidalgo S ^a   Sanchez Hidalgo, M ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

HO1; inflammation; macrophages; melatonin; NF B; Nrf2; p38 MAPK

Indexed keywords

CYCLOOXYGENASE 2; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRITE; PROSTAGLANDIN E SYNTHASE 1; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

HO1; INFLAMMATION; MACROPHAGES; MELATONIN; NF-ΚB; NRF2; P38 MAPK;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HEME OXYGENASE-1; INTRAMOLECULAR OXIDOREDUCTASES; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MELATONIN; MEMBRANE PROTEINS; MICE; NF-E2-RELATED FACTOR 2; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 84890280909     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12428     Document Type: Article

References (78)

1. Adams DO, Hamilton TA, (1984). The cell biology of macrophage activation. Annu Rev Immunol 2: 283-318.
2. Alarcón de la Lastra C, Motilva V, Martín MJ, Nieto A, Barranco MD, Cabeza J, et al. (1999). Protective effect of melatonin on indomethacin-induced gastric injury in rats. J Pineal Res 26: 101-107.
3. Alexander SPH, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
4. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA, (2003). The chemistry of melatonin's interaction with reactive species. J Pineal Res 34: 1-10.
5. Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD, (2002). Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J Leukoc Biol 71: 677-685.
6. Barton GM, Medzhitov R, (2003). Toll-like receptor signaling pathways. Science 300: 1524-1525.
7. Bradford MM, (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
8. Brüne B, Dehne N, Grossmann N, Jung M, Namgaladze D, Schmid T, et al. (2013). Redox control of inflammation in macrophages. Antioxid Redox Signal 19: 595-637.
9. Bubenik GA, (2002). Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47: 2336-2348.
10. Carrillo-Vico A, García-Pergañeda A, Naji L, Calvo JR, Romero MP, Guerrero JM, (2003). Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell Mol Life Sci 60: 2272-2278.
11. Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, García- Mauriño S, Reiter RJ, et al. (2004). Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 18: 537-539.
12. Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM, (2013). Melatonin: buffering the immune system. Int J Mol Sci 14: 8638-8683.
13. Chang WT, Huang WC, Liou CJ, (2012). Evaluation of the anti-inflammatory effects of phloretin and phlorizin in lipopolysaccharide-stimulated mouse macrophages. Food Chem 134: 972-979.
14. Choi EY, Jin JY, Lee JY, Choi JI, Choi IS, Kim SJ, (2011). Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity. J Pineal Res 50: 197-206.
15. De La Lastra CA, Cabeza J, Motilva V, Martin MJ, (1997). Melatonin protects against gastric ischemia-reperfusion injury in rats. J Pineal Res 23: 47-52.
16. Deng WG, Tang ST, Tseng HP, Wu KK, (2006). Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108: 518-524.
17. Dreger H, Westphal K, Weller A, Baumann G, Stangl V, Meiners S, et al. (2009). Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res 83: 354-361.
18. Esposito E, Genovese T, Caminiti R, Bramanti P, Meli R, Cuzzocrea S, (2009). Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury. J Pineal Res 46: 79-86.
19. Faillace MP, Cutrera R, Sarmiento MI, Rosenstein RE, (1995). Evidence for local synthesis of melatonin in golden hamster retina. Neuroreport 6: 2093-2095.
20. Guerrero JM, Reiter RJ, (2002). Melatonin-immune system relationships. Curr Top Med Chem 2: 167-179.
21. Guha M, Mackman N, (2001). LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94.
22. Hardeland R, (2009). Neuroprotection by radical avoidance: search for suitable agents. Molecules 14: 5054-5102.
23. Helenius M, Kyrylenko S, Vehviläinen P, Salminen A, (2001). Characterization of aging-associated up-regulation of constitutive nuclear factor-kappa B binding activity. Antioxid Redox Signal 3: 147-156.
24. Hill-Kapturczak N, Thamilselvan V, Liu F, Nick HS, Agarwal A, (2001). Mechanism of heme oxygenase-1 gene induction by curcumin in human renal proximal tubule cells. Am J Physiol Renal Physiol 281: F851-F859.
25. Huether G, Poeggeler B, Reimer A, George A, (1992). Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 51: 945-953.
26. Jaiswal AK, (2004). Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36: 1199-1207.
27. Joo SS, Yoo YM, (2009). Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res 47: 8-14.
28. Jung CH, Kim JH, Park S, Kweon DH, Kim SH, Ko SG, (2010a). Inhibitory effect of Agrimonia pilosa Ledeb. on inflammation by suppression of iNOS and ROS production. Immunol Invest 39: 159-170.
29. Jung KH, Hong SW, Zheng HM, Lee HS, Lee H, Lee DH, et al. (2010b). Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. J Pineal Res 48: 239-250.
30. Kang IS, Kim C, (2013). Taurine chloramine administered in vivo increases NRF2-regulated antioxidant enzyme expression in murine peritoneal macrophages. Adv Exp Med Biol 775: 259-267.
31. Kang JW, Lee SM, (2012). Melatonin inhibits type 1 interferon signaling of toll-like receptor 4 via heme oxygenase-1 induction in hepatic ischemia/reperfusion. J Pineal Res 53: 67-76.
32. Kilic U, Kilic E, Tuzcu Z, Tuzcu M, Ozercan IH, Yilmaz O, et al. (2013). Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf2/HO1 pathway. Nutr Metab (Lond) 10: 7-15.
33. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
34. Kim KJ, Yoon KY, Lee BY, (2012). Low molecular weight fucoidan from the sporophyll of Undaria pinnatifida suppresses inflammation by promoting the inhibition of mitogen-activated protein kinases and oxidative stress in RAW264.7 cells. Fitoterapia 83: 1628-1635.
35. Kudo I, Murakami M, (2005). Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol 38: 633-638.
36. Kyriakis JM, Avruch J, (2012). Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92: 689-737.
37. Lawrence T, Willoughby DA, Gilroy DW, (2002). Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2: 787-795.
38. Lazarus M, Kubata BK, Eguchi N, Fujitani Y, Urade Y, Hayaishi O, (2002). Biochemical characterization of mouse microsomal prostaglandin E synthase-1 and its colocalization with cyclooxygenase-2 in peritoneal macrophages. Arch Biochem Biophys 397: 336-341.
39. Lee HN, Surh YJ, (2012). Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. Biochem Pharmacol 84: 1340-1350.
40. Lenardo MJ, Baltimore D, (1989). NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229.
41. Li DY, Xue MY, Geng ZR, Chen PY, (2012). The suppressive effects of Bursopentine (BP5) on oxidative stress and NF-κB activation in lipopolysaccharide-activated murine peritoneal macrophages. Cell Physiol Biochem 29: 9-20.
42. Li Q, Guo Y, Ou Q, Cui C, Wu WJ, Tan W, et al. (2009). Gene transfer of inducible nitricoxide synthase affords cardioprotection by upregulating heme oxygenase-1via a nuclear factor-{kappa}B-dependent pathway. Circulation 120: 12229lat.
43. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
44. Marçola M, da Silveira Cruz-Machado S, Fernandes PA, Monteiro AW, Markus RP, Tamura EK, (2013). Endothelial cell adhesiveness is a function of environmental lighting and melatonin level. J Pineal Res 54: 162-169.
45. Mayo JC, Sainz RM, Tan DX, Hardeland R, Leon J, Rodriguez C, et al. (2005). Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 165: 139-149.
46. Moorcroft MJ, Davis J, Compton RG, (2001). Detection and determination of nitrate and nitrite: a review. Talanta 54: 785-803.
47. Munoz L, Ammit AJ, (2010). Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology 58: 561-568.
48. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, et al. (2000). Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792.
49. Murakami Y, Machino M, Fujisawa S, (2012). Porphyromonas gingivalis fimbria-induced expression of inflammatory cytokines and cyclooxygenase-2 in mouse macrophages and its inhibition by the bioactive compounds fibronectin and melatonin. ISRN Dent 2012: 350859.
50. Muxel SM, Pires-Lapa MA, Monteiro AW, Cecon E, Tamura EK, Floeter-Winter LM, et al. (2009). NF-κB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N- acetyltransferase (AA-NAT) gene. PLoS ONE 7: e52010.
51. Naidu S, Wijayanti N, Santoso S, Kietzmann T, Immenschuh S, (2008). An atypical NFkappaB-regulated pathway mediates phorbol ester-dependent hemeoxygenase-1 gene activation in monocytes. J Immunol 181: 4113-4181.
52. Negi G, Kumar A, Sharma SS, (2011). Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. J Pineal Res 50: 124-131.
53. Niranjan R, Nath C, Shukla R, (2012). Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat astrocytoma cells, C6. Free Radic Res 46: 1167-1177.
54. Owuor ED, Kong AN, (2002). Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol 64: 765-770.
55. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S, (2010). Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80: 1895-1903.
56. du Plessis SS, Hagenaar K, Lampiao F, (2010). The in vitro effects of melatonin on human sperm function and its scavenging activities on NO and ROS. Andrologia 42: 112-116.
57. Qi HY, Shelhamer JH, (2005). Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J Biol Chem 280: 38969-38975.
58. Radogna F, Diederich M, Ghibelli L, (2010). Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 80: 1844-1852.
59. Reiter RJ, (1991). Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 12: 151-180.
60. Reiter RJ, Paredes SD, Manchester LC, Tan DX, (2009). Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 44: 175-200.
61. Reiter RJ, Rosales-Corral S, Coto-Montes A, Boga JA, Tan DX, Davis JM, et al. (2011). The photoperiod, circadian regulation and chronodisruption: the requisite interplay between the suprachiasmatic nuclei and the pineal and gut melatonin. J Physiol Pharmacol 62: 269-274.
62. Sánchez-Hidalgo M, Martín AR, Villegas I, Alarcón De La Lastra C, (2005). Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol 69: 1733-1744.
63. Sánchez-Hidalgo M, Guerrero Montávez JM, Carrascosa-Salmoral MEP, Naranjo Gutierrez MEC, Lardone PJ, de la Lastra Romero CA, (2009). Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging. J Pineal Res 46: 29-35.
64. Sánchez-Miranda E, Lemus-Bautista J, Pérez S, Pérez-Ramos J, (2013). Effect of kramecyne on the inflammatory response in lipopolysaccharide-stimulated peritoneal macrophages. Evid Based Complement Alternat Med 2013: 762020-762028.
65. Scheidereit C, (2006). IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: 6685-6705.
66. Schneider M, (2013). Collecting resident or thioglycollate-elicited peritoneal macrophages. Methods Mol Biol 1031: 37-40.
67. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112.
68. Slominski A, Pisarchik A, Semak I, Sweatman T, Wortsman J, Szczesniewski A, et al. (2002). Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 16: 896-898.
69. Soehnlein O, Lindbom L, (2010). Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10: 427-439.
70. Tak PP, Firestein GS, (2001). NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7-11.
71. Tamura H, Takasaki A, Taketani T, Tanabe M, Kizuka F, Lee L, et al. (2013). Melatonin as a free radical scavenger in the ovarian follicle. Endocr J 60: 1-13.
72. Tan DX, Manchester LC, Reiter RJ, Qi WB, Zhang M, Weintraub ST, et al. (1999). Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim Biophys Acta 1472: 206-214.
73. Wang JY, Wen LL, Huang YN, Chen YT, Ku MC, (2006). Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 12: 3521-3533.
74. Xia MZ, Liang YL, Wang H, Chen X, Huang YY, Zhang ZH, et al. (2012). Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. J Pineal Res 53: 325-334.
75. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee T, et al. (1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophage. Science 256: 225-228.
76. Yong HY, Koh MS, Moon A, (2009). The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin Investig Drugs 18: 1893-1905.
77. Zhang QH, Zhou ZS, Lu GS, Song B, Guo JX, (2013). Melatonin improves bladder symptoms and may ameliorate bladder damage via increasing HO1 in rats. Inflammation 36: 651-657.
78. Zhang S, Li W, Gao Q, Wei T, (2004). Effect of melatonin on the generation of nitric oxide in murine macrophages. Eur J Pharmacol 501: 25-30.